Abiopharma

Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma

Ceva, Inc. Announces Second Quarter 2026 Financial Results

Hello Group to Report Second Quarter 2026 Results on September 3, 2026

Western Midstream Announces Second-Quarter Post-Earnings Interview with Chief Financial Officer, Kristen Shults and Participation in Upcoming Investor Conferences

Palladyne AI Appoints Former MARSOC Commander and U.S. Special Operations Command Chief of Staff Maj. Gen. Mark A. "Droopy" Clark (Ret.) to Defense Advisory Board

Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update

BrewDog Claims Londons Summer Park Season with ‘Park IPA’

Shoulder Innovations Promotes Jon Osborne to Chief Commercial Officer

Jade Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Ceribell Receives FDA Clearance for Advanced Epileptiform Abnormality Detection and Artifact Reduction for Its Cloud-Based Portal, Delivering Greater Precision for Critical-Care EEG Review